Once activated by MICA via NKG2D, NK cells have the ability to kill self-cells deficient in MHC class I molecules, a property important to immunosurveillance as tumor cells are known to evade the adaptive immune system through MHC class I downregulation [15]. The gene discussed is MICA; the disease is neoplasm.